Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)
接受风险适应疗法治疗的髓母细胞瘤儿童的临床和分子特征结果：国际 III 期试验 (SJMB03) 的结果
期刊:Journal of Clinical Oncology
影响因子:42.1
doi:10.1200/JCO.20.01372
Amar Gajjar, Giles W Robinson, Kyle S Smith, Tong Lin, Thomas E Merchant, Murali Chintagumpala, Anita Mahajan, Jack Su, Eric Bouffet, Ute Bartels, Tal Schechter, Tim Hassall, Thomas Robertson, Wayne Nicholls, Sridharan Gururangan, Kristin Schroeder, Michael Sullivan, Greg Wheeler, Jordan R Hansford,
